Compare ADMA Biologics Inc (ADMA) vs Domino's Pizza, Inc. (DPZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Domino's Pizza, Inc. — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while Domino's Pizza, Inc. trades at $356.98 (market cap $11.82B). The key difference: Domino's Pizza, Inc. is far larger — about 5.3× ADMA Biologics Inc's market cap, and Domino's Pizza, Inc. pays a 2.23% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | DPZ | |
|---|---|---|
Market Cap | $2.22B | $11.82B |
Sector | Health | Consumer Cyclical |
52-Week High | $20.38 | $467.30 |
52-Week Low | $7.60 | $282.89 |
Enterprise Value | $2.29B | $16.78B |
Dividend Yield | — | 2.23% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Domino's Pizza, Inc.
Domino's is a restaurant operator and franchiser with nearly 19,000 global stores across more than 90 international markets at the end of 2021. The firm generates revenue through the sales of pizza, wings, salads, and sandwiches at company-owned stores, royalty and marketing contributions from franchise-operated stores, and its network of 25 domestic (and five Canadian) dough manufacturing and supply chain facilities, which centralize purchasing, preparation, and last-mile delivery for the firm's U.S. and Canadian restaurants. With roughly $17.7 billion in 2021 system sales, Domino's is the largest player in the global pizza market, ahead of Pizza Hut, Papa John's, and Little Caesars.
Read more on DPZ →
